Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipase family member K (LIPK) is an enzyme belonging to the lipase family, predicted to possess lipoprotein lipase activity, and is primarily expressed in keratinocytes where it plays a highly specific role in the terminal steps of differentiation and cornification[1][3][4][6]. It is believed to be essential for lipid metabolism in the most differentiated layers of the epidermis[4][5]. Currently, there is no evidence that LIPK is a therapeutic target, nor are there drugs known to modulate its activity. No direct role in human diseases or safety concerns related to therapeutic modulation have been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipase family member K (LIPK).